Bayer Lecture Chair on dual targeting theradiagnostics as a potential new cancer therapy

Faculteit

Geneeskunde

Schenker

Bayer NV

Datum ondertekening

1 october 2009

Duur

3 years: 1 october 2009 – 30 september 2012

Doelstelling

The purpose of the sponsoring and the Chair is, amongst others, to promote and to support additional academic based scientific research, on dual targeting theradiagnostics as a potential new cancer therapy.

Titularis aan de K.U. Leuven

Prof.dr. Yicheng Ni